IF·01active
Media relations and tier one placements
Named reporters at MedTech Dive, MobiHealthNews, Fierce Biotech, Modern Healthcare, and the business desks above them.
The healthtech PR agency that commits to placement targets in writing and refunds you if we miss
We pitch the health IT, medtech, and business reporters that hospital buyers, clinicians, and investors actually read, then aim that coverage at your rankings and at the AI answers procurement teams now use to build a shortlist. Outlet tiers, placement targets, and dates go in writing before kickoff, behind a 100% guarantee: you get the agreed results or your money back.
Program vitalsalarm limits set before kickoff
AdmittingStableThe stakes
What being unknown costs a healthtech company
Most companies searching for a healthtech PR agency have already cleared the hard part. The product works. The pilot data holds. Two clinical champions will say so on a call. Outside that room, nobody has heard of you.
Health systems buy on recognition before evidence. A clinician, a CIO, a security reviewer, and a finance lead each research you separately, and the vendors that survive are the ones already visible in the trade press. A competitor with thinner data and a working press program takes the quote in every article about your category, and your next round gets priced against their visibility, not your product.
The work
What our healthtech PR agency work covers
Every scope starts from the audience that decides your revenue: hospital procurement teams, clinicians, payers, channel partners, or investors.
IF·02active
Launch and milestone PR
510(k) clearances, De Novo grants, CE marking, funding rounds, EHR integrations, health system go lives, and pilots that convert to contracts.
IF·03active
Thought leadership and executive positioning
Bylines, expert commentary, and podcast slots for founders, chief medical officers, and heads of clinical operations.
IF·04active
Analyst and investor communications
Briefings for the analysts your buyers cite and the funds reading your coverage before they open your deck.
IF·05active
Crisis and issues management
Outages, security incidents, recalls, and the statement written before the reporter's email arrives.
IF·06active
Digital PR, GEO, and measurement
Earned coverage aimed at the pages that convert, reported against the targets in your scope.
Full menu at public relations services.
Two clocks
What a medtech PR agency handles that a digital health program does not
Medtechregulatory and evidence milestones
Bring us in as a medtech PR agency and the calendar runs on regulatory and evidence milestones: 510(k) clearance, De Novo, CE marking under MDR or IVDR, published clinical results, reimbursement decisions, and adoption inside named health systems. The story has to survive a surgeon reading it and a reimbursement lead checking it.
Digital health and health ITdifferent proof
Digital health and health IT run on different proof: pilot outcomes, interoperability, security posture, and time to value for an IT team already three projects behind. Software sold into hospitals is enterprise B2B with a clinical safety layer on top and a buying cycle that rewards patience. Diagnostics, therapeutics, and provider brands keep their own clocks, at biotech PR and healthcare PR.
Compliance
Compliance belongs in the scope, not in an apology later
This is where a generalist agency gets expensive. Patient stories need consent and a business associate agreement before anyone touches identifiable data, so HIPAA shapes the storytelling from the first draft, not the final review. Claims about an uncleared device or an unapproved indication are an FDA problem, not a copy preference. European launches answer to MDR, IVDR, and GDPR the moment a case study crosses a border. If your regulatory lead wants eyes on every pitch, we build that review into the timeline.
The strip
What the first 90 days look like
Day 7
Week one: the scope goes in writing.
Discovery with your clinical and commercial leads, messaging a physician will not wince at, a share of voice read against named competitors, and a target media list. Outlet tiers, placement targets, timelines, and deliverables are signed before any money moves.
Day 21
Weeks two and three: pitching starts.
Named health IT, medtech, and trade reporters, plus expert commentary pitched into stories already running that week.
Day 45
Days 30 to 45: first coverage.
Trade and clinical titles land first, because that is where procurement committees and referring clinicians read.
Day 90
Day 90: tier one and an honest review.
National business desks, executive bylines placed, and a review against the targets you signed rather than the activity we logged.
Every month after that: proactive pitching against the agreed list, an agreed volume of bylines and reactive opportunities, and reporting on placements against target, share of voice, referring domains, branded search movement, and where AI engines name you. Forbes clients typically see a first opportunity within 4 to 8 weeks, which gives you a sense of pace.
AI answers
Getting cited when a hospital asks AI which vendors to shortlist
Vendor research moved. A CIO asks ChatGPT, Gemini, or Perplexity which remote monitoring platforms integrate with their EHR, reads one answer, and builds the shortlist from it. If a model cannot name you, you are not in the room when the room forms.
Models repeat what they can verify: earned coverage in publications they already crawl, entity signals that stay consistent across your site and the trade press, structured data stating what your product does and who it is cleared for, and plain answers on your own pages to what buyers ask out loud. No link vendor manufactures a feature in MedTech Dive. That is why PR and search sit in one team here rather than two contracts with separate excuses, and why the same coverage feeds your patient facing rankings.
Five checks
How to choose a healthtech PR agency
Five checks separate a shortlist from a pitch deck.
01
Does the agency name the regulations your category lives under, or does compliance appear once as a keyword.
answered02
Who runs the account after the pitch, and are they in the room today.
answered03
Are the case studies healthtech, or enterprise clients with a health logo attached.
answered04
Are placement targets and timelines written into the contract, or described as a philosophy.
answered05
And what happens if the agency misses. Most answers stop at the fourth question.
ours: a refundWhy AceIt
Why hire AceIt as your healthtech PR agency
Healthtech buyers get burned in a predictable way. You sign a twelve month retainer and the excuses arrive on schedule: the category is early, the clinical data is embargoed, hospital sales cycles are slow, wait for HIMSS.
Our risk, priced inthe contract
100% · agreed results or your money backAn annual prepay to qualifyTerms buried in an FAQ- The work and the agreed deliverables, guaranteed
A year later you have a hit report padded with syndicated reprints, coverage in outlets no health system reads, no lift in branded search, no AI engine naming you, and a retainer already spent. The agency keeps the fee. You keep the problem.
So we priced our own risk into the contract instead. Placement targets, outlet tiers, timelines, and deliverables are agreed before kickoff, and if we do not deliver what we committed to, on the timeline we committed to, you get your money back. No annual prepay to qualify, no terms buried in an FAQ. We guarantee the work and the agreed deliverables rather than pretending we control whether one named journalist says yes. Scoping it that way is what lets us sign the refund at all.
Three things you can check on the first call. Senior people run your account, so nobody learns interoperability on your budget. Replies land in 1 to 2 hours, which counts most on the day a security incident turns into a reporter's question. PR, SEO, and web run as one team out of Austin.
Receipts
The numbers we can show you today
1M+Brand impressions Vezbi, a community super app, earned during its U.S. expansion, all of it from organic PR
50+Placements the Forbes program has secured across 12+ industries
4,200+Visits one anonymized client turned a single feature into, with a 38% lift in branded search and 12 secondary pickups
DA 94Authority of the backlink that same feature earned
Clients have been featured in
More results sit at case studies, Vezbi, and the Forbes program. Clients have been featured in USA Today Network, Forbes, Bloomberg, TechCrunch, VentureBeat, Wired, Inc., CNET, and Fast Company.
The number
What a healthtech PR agency costs
Eight of the ten pages ranking for this term will not tell you. It is a contact form or a call. The two that do publish numbers gate the cheapest tier behind annual prepayment.
AceIt · published
Forbes campaigns priced in writing before kickoffPrograms pairing earned media with search run mid five figures to six figures annually against a 12 month roadmap.
We publish ours on the pricing page. Forbes campaigns are scoped and priced in writing before kickoff. Programs pairing earned media with search run mid five figures to six figures annually against a 12 month roadmap. Project, retainer, and performance oriented models are all available, and scope and price are settled on the strategy call, in writing, before you commit anything.
The honest filter
Who we do our best work for
Indicatedit fits
- Device makers with clearance and a launch ahead
- Digital health platforms selling to skeptical clinicians
- Health IT and interoperability vendors
- Diagnostics companies
- Funded startups that need hospitals and investors to know the name
Contraindicatednot this page
- Anyone who wants a named national desk promised by Friday
- Anyone shopping purely on monthly rate
- Anyone whose claims would not survive a regulator reading them
If the evidence is not ready, we will say so on the first call.
Questions
Asked before every healthtech engagement
Anything else, email [email protected] and it comes back in 1 to 2 hours.
A healthtech PR agency earns media coverage for companies building medical devices, digital health platforms, health IT, and diagnostics. The work covers messaging, media relations with health and trade reporters, launch support around clearances and funding rounds, executive visibility, and crisis response. The point is credibility with the people who decide adoption: clinicians, hospital procurement teams, payers, partners, and investors.
A medtech PR firm turns regulatory and clinical milestones into coverage buyers trust. That means announcing 510(k) clearances, De Novo grants, and CE marking under MDR or IVDR, translating clinical evidence into a story a general reporter can run without mangling the science, positioning your chief medical officer as a source, briefing analysts, and handling recalls or safety issues when they land.
Specialist healthcare and healthtech programs generally start around $5,000 to $10,000 a month, and national firms quote well above that. Our prices are published rather than hidden behind a form, on the pricing page. Forbes campaigns are scoped and priced in writing before kickoff, and programs pairing earned media with search run mid five figures to six figures a year. Scope and price go in writing before kickoff.
Almost none do, and any agency promising that a specific journalist will say yes is selling you something else. We guarantee the work and the agreed deliverables. Placement targets, outlet tiers, timelines, and deliverables are agreed before kickoff, and if we do not deliver what we committed to, on the timeline we committed to, you get your money back.
It can be, and it has to be. Any patient story, testimonial, or case study involving identifiable health information needs documented authorization, and an agency handling that data on your behalf should sign a business associate agreement first. Most healthtech PR runs on deidentified outcomes, aggregate data, and clinician voices instead, which keeps the story strong and the exposure at zero.
Coverage does three things a deck cannot. It proves the category is real to partners who have not looked at it yet, it gives your existing investors something to forward, and it shows traction diligence can verify independently. Announcement coverage also sets your valuation narrative before the term sheet conversation, then keeps working for recruiting and sales afterward.
Next step
Get the media plan first, decide after
Send us your domain, your next milestone, and the two competitors who keep getting quoted instead of you. Back comes the story angles we would build, the health IT and medtech titles we would pitch first, the date we expect first coverage, and the exact numbers we would sign. Every engagement carries a 100% guarantee: you get the agreed results or your money back.
Every engagement carries a 100% guarantee: you get the agreed results or your money back